These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1793783)

  • 21. Total and unbound concentrations of quinidine and 3-hydroxyquinidine at steady state.
    Wooding-Scott RA; Visco J; Slaughter RL
    Am Heart J; 1987 Feb; 113(2 Pt 1):302-6. PubMed ID: 3812182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Theophylline steady state pharmacokinetics is not altered by omeprazole.
    Taburet AM; Geneve J; Bocquentin M; Simoneau G; Caulin C; Singlas E
    Eur J Clin Pharmacol; 1992; 42(3):343-5. PubMed ID: 1577056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of the pharmacokinetic and pharmacodynamic properties of quinine and quinidine in healthy Thai males.
    Karbwang J; Davis TM; Looareesuwan S; Molunto P; Bunnag D; White NJ
    Br J Clin Pharmacol; 1993 Mar; 35(3):265-71. PubMed ID: 8471402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of pharmacokinetic interaction after administration of lansoprazole or omeprazole with prednisone.
    Cavanaugh JH; Karol MD
    J Clin Pharmacol; 1996 Nov; 36(11):1064-71. PubMed ID: 8973995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pirmenol: an antiarrhythmic drug with unique electrocardiographic features--a double-blind placebo-controlled comparison with quinidine.
    Salerno DM; Fifield J; Farmer C; Hodges M
    Clin Cardiol; 1991 Jan; 14(1):25-32. PubMed ID: 2019027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of cytochrome P2C19 in R-warfarin pharmacokinetics and its interaction with omeprazole.
    Uno T; Sugimoto K; Sugawara K; Tateishi T
    Ther Drug Monit; 2008 Jun; 30(3):276-81. PubMed ID: 18520598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of ketoconazole and quinidine on pharmacokinetics of pactimibe and its plasma metabolite, R-125528, in humans.
    Kotsuma M; Tokui T; Freudenthaler S; Nishimura K
    Drug Metab Dispos; 2008 Aug; 36(8):1505-11. PubMed ID: 18448569
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of omeprazole and cimetidine on plasma diazepam levels.
    Andersson T; Andrén K; Cederberg C; Edvardsson G; Heggelund A; Lundborg P
    Eur J Clin Pharmacol; 1990; 39(1):51-4. PubMed ID: 2276389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral phenytoin pharmacokinetics during omeprazole therapy.
    Prichard PJ; Walt RP; Kitchingman GK; Somerville KW; Langman MJ; Williams J; Richens A
    Br J Clin Pharmacol; 1987 Oct; 24(4):543-5. PubMed ID: 3689634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of quinidine, verapamil and nifedipine on the pharmacokinetics and pharmacodynamics of digitoxin during steady state conditions.
    Kuhlmann J
    Arzneimittelforschung; 1987 May; 37(5):545-8. PubMed ID: 3619976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Omeprazole on the Pharmacokinetics of Rosuvastatin in Healthy Male Volunteers.
    Shah Y; Iqbal Z; Ahmad L; Khuda F; Khan A; Khan A; Khan MI; Ismail
    Am J Ther; 2016; 23(6):e1514-e1523. PubMed ID: 25719441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heterogeneous effect of quinidine on the ventricular depolarization process assessed by the spatial velocity electrocardiogram of the QRS complex. Preliminary report of a new investigative method.
    Fareh S; Arnaud P; Fayn J; Nony P; Girard P; Haugh M; Girard I; Ferry S; Boissel JP; Rubel P
    Cardiology; 1996; 87(2):129-33. PubMed ID: 8653729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Propranolol steady-state pharmacokinetics are unaltered by omeprazole.
    Henry D; Brent P; Whyte I; Mihaly G; Devenish-Meares S
    Eur J Clin Pharmacol; 1987; 33(4):369-73. PubMed ID: 3443142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of omeprazole treatment on diazepam plasma levels in slow versus normal rapid metabolizers of omeprazole.
    Andersson T; Cederberg C; Edvardsson G; Heggelund A; Lundborg P
    Clin Pharmacol Ther; 1990 Jan; 47(1):79-85. PubMed ID: 2104790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacodynamics of 3-hydroxyquinidine alone and in combination with quinidine in healthy persons.
    Vozeh S; Bindschedler M; Ha HR; Kaufmann G; Guentert TW; Follath F
    Am J Cardiol; 1987 Mar; 59(6):681-4. PubMed ID: 3825912
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of quinidine on pharmacokinetics and pharmacodynamics of digitoxin achieving steady-state conditions.
    Kuhlmann J; Dohrmann M; Marcin S
    Clin Pharmacol Ther; 1986 Mar; 39(3):288-94. PubMed ID: 3512148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of diclofenac, disulfiram, itraconazole, grapefruit juice and erythromycin on the pharmacokinetics of quinidine.
    Damkier P; Hansen LL; Brosen K
    Br J Clin Pharmacol; 1999 Dec; 48(6):829-38. PubMed ID: 10594487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of effect of perampanel on QT interval duration: Results from a thorough QT analysis and pooled partial seizure Phase III clinical trials.
    Yang H; Laurenza A; Williams B; Patten A; Hussein Z; Ferry J
    Epilepsy Res; 2015 Aug; 114():122-30. PubMed ID: 26088895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of omeprazole on the pharmacokinetics of paricalcitol in healthy subjects.
    Palaparthy R; Pradhan RS; Chan J; Rieser M; Chira T; Galitz L; Awni W; Williams LA
    Biopharm Drug Dispos; 2007 Mar; 28(2):65-71. PubMed ID: 17173278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of single- and multiple-dose omeprazole treatment on nifedipine pharmacokinetics and effects in healthy subjects.
    Soons PA; van den Berg G; Danhof M; van Brummelen P; Jansen JB; Lamers CB; Breimer DD
    Eur J Clin Pharmacol; 1992; 42(3):319-24. PubMed ID: 1577051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.